Home pageSNPHY โข OTCMKTS
add
Santen Pharmaceutical ADR Representing Ord Shs
Chiusura precedente
11,54ย $
Intervallo giornaliero
11,75ย $ - 11,75ย $
Intervallo annuale
8,65ย $ - 13,00ย $
Cap di mercato
572,44ย Mld JPY
Volume medio
4898,00
Notizie del mercato finanziario
Dati finanziari
Conto economico
Entrate
Utile netto
| (JPY) | mar 2025info | Variazione Y/Y |
|---|---|---|
Entrate | 77,23ย Mld | -2,40% |
Spese di gestione | 32,01ย Mld | 1,78% |
Utile netto | 8,79ย Mld | 30.213,79% |
Margine di profitto netto | โ | โ |
Utili per azione | โ | โ |
EBITDA | 18,48ย Mld | -10,21% |
Aliquota fiscale effettiva | โ | โ |
Stato patrimoniale
Totale attivo
Totale passivo
| (JPY) | mar 2025info | Variazione Y/Y |
|---|---|---|
Investimenti cash/breve termine | 93,00ย Mld | -1,68% |
Totale attivo | 409,28ย Mld | -6,06% |
Totale passivo | 124,10ย Mld | -4,78% |
Patrimonio netto totale | 285,18ย Mld | โ |
Azioni in circolazione | 341,36ย Mln | โ |
Prezzo/valore contabile | 0,01 | โ |
Redditivitร dell'attivo | 8,72% | โ |
Rendimento sul capitale | 12,39% | โ |
Flusso di cassa
Flusso di cassa netto
| (JPY) | mar 2025info | Variazione Y/Y |
|---|---|---|
Utile netto | 8,79ย Mld | 30.213,79% |
Liquiditร di esercizio | 18,89ย Mld | 43,01% |
Contanti da investimenti | -976,00ย Mln | -134,62% |
Contanti da finanziamenti | -861,00ย Mln | 68,24% |
Flusso di cassa netto | 15,15ย Mld | 20,67% |
Flusso di cassa libero | 13,86ย Mld | 34,37% |
Informazioni
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products. Wikipedia
Fondazione
1890
Sito web
Dipendenti
3.849
